1. Home
  2. EZPW vs IMNM Comparison

EZPW vs IMNM Comparison

Compare EZPW & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EZPW
  • IMNM
  • Stock Information
  • Founded
  • EZPW 1989
  • IMNM 2006
  • Country
  • EZPW United States
  • IMNM United States
  • Employees
  • EZPW N/A
  • IMNM N/A
  • Industry
  • EZPW Other Specialty Stores
  • IMNM Medicinal Chemicals and Botanical Products
  • Sector
  • EZPW Consumer Discretionary
  • IMNM Health Care
  • Exchange
  • EZPW Nasdaq
  • IMNM Nasdaq
  • Market Cap
  • EZPW 1.0B
  • IMNM 987.1M
  • IPO Year
  • EZPW 1991
  • IMNM 2020
  • Fundamental
  • Price
  • EZPW $18.80
  • IMNM $13.83
  • Analyst Decision
  • EZPW Strong Buy
  • IMNM Strong Buy
  • Analyst Count
  • EZPW 3
  • IMNM 9
  • Target Price
  • EZPW $20.00
  • IMNM $24.89
  • AVG Volume (30 Days)
  • EZPW 945.0K
  • IMNM 2.0M
  • Earning Date
  • EZPW 11-12-2025
  • IMNM 11-12-2025
  • Dividend Yield
  • EZPW N/A
  • IMNM N/A
  • EPS Growth
  • EZPW 23.23
  • IMNM N/A
  • EPS
  • EZPW 1.29
  • IMNM N/A
  • Revenue
  • EZPW $1,232,018,000.00
  • IMNM $12,589,000.00
  • Revenue This Year
  • EZPW $10.11
  • IMNM N/A
  • Revenue Next Year
  • EZPW $6.57
  • IMNM $154.70
  • P/E Ratio
  • EZPW $14.62
  • IMNM N/A
  • Revenue Growth
  • EZPW 8.31
  • IMNM 16.74
  • 52 Week Low
  • EZPW $11.02
  • IMNM $5.15
  • 52 Week High
  • EZPW $19.24
  • IMNM $15.13
  • Technical
  • Relative Strength Index (RSI)
  • EZPW 65.98
  • IMNM 67.38
  • Support Level
  • EZPW $17.61
  • IMNM $11.25
  • Resistance Level
  • EZPW $19.04
  • IMNM $12.00
  • Average True Range (ATR)
  • EZPW 0.52
  • IMNM 1.01
  • MACD
  • EZPW -0.04
  • IMNM 0.40
  • Stochastic Oscillator
  • EZPW 76.78
  • IMNM 87.06

About EZPW EZCORP Inc. Non Voting

EZCORP Inc is a United States-based company engaged in offering pawn loans in the United States and Mexico. It also offers short-term unsecured loans and other consumer financial products, and buy and sell second-hand goods. The operating segments of the company are us Pawn, Latin America Pawn, and other international. us Pawn segment includes all pawn activities in the United States. Latin America Pawn segment includes all pawn activities in Mexico and other parts of Latin America. The company generates revenue from merchandise sales, jewelry scrapping sales, and pawn service charges, of which key revenue is derived from the merchandise sales which are primarily collateral forfeited from pawn lending operations and used merchandise purchased from the customers.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: